17 Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
The FDA has granted it Fast Track designation for reviewing and potentially approving it as a weight loss medication for people without diabetes
If smoking cessation is part of your health goal alongside weight management, your PlexusDx provider can discuss how semaglutide fits into a comprehensive plan that may include behavioral support and proven quit-smoking medications
For those on semaglutide who want equivalent conversion charts and dosing references, we maintain comprehensive guides for semaglutide 5 mg/mL dosage charts , semaglutide mixing charts , and semaglutide syringe dosage conversion charts
The study found that strength training and enough protein were key to keeping muscle while losing weight, as well as getting guidance from an obesity medicine specialist